Skip to main content

Premium Supplement NMN KIWAMI Made in Japan with FDA Compliance Seeks Strategic U.S. Distribution Partnerships

Clinically validated with confirmed telomere lengthening and used in Japanese medical institutions and IV therapies, this product supports distributor wellness portfolios with a 95% repeat rate.

Japan, 3rd Mar 2026 – Asa Pharmaceutical Co., Ltd. (Headquarters: Minato Ward, Tokyo; President and CEO: Tomoko Iwase), a manufacturer and distributor of health supplements, announced that effective Monday, January 26, 2026, it will significantly strengthen its supply structure for the Japanese-made NMN supplement NMN KIWAMI in the North American market and will officially begin accepting applications for local sales distributors. 

NMN KIWAMI is sold exclusively through medical institutions in Japan due to its high quality and is also used as a raw material for NMN intravenous therapy, positioning it as a professional-use product. With a repeat purchase rate reaching 95%, NMN KIWAMI enters the rapidly expanding U.S. longevity market as a uniquely positioned supplement that combines advanced Japanese manufacturing standards with full compliance with U.S. regulatory requirements, aiming to expand market share in collaboration with strategic local partners.

Four Reasons Why U.S. Distributors Should Choose NMN KIWAMI

1. Exceptional Compliance and Safety (FDA & Informed Sport)

Regulatory compliance represents the highest barrier in the U.S. supplement market. NMN KIWAMI uses domestically produced raw materials that meet FDA standards and has obtained Informed Sport certification, which complies with World Anti-Doping Agency (WADA) guidelines. This allows distributors serving professional athletes and celebrities to add the product to their portfolios with confidence.

 2. Reliability Based on Clinical Evidence

Human clinical trials involving subjects aged 50 to 61 demonstrated improvements in insulin resistance and triglyceride levels, as well as confirmed lengthening of telomeres, a key biomarker of aging. These data provide strong appeal to evidence-driven, high-income consumer segments in the United States.

3. Made in Japan Quality and Advanced Delivery Technology

100% pure Japanese NMN: A proprietary manufacturing process achieves high NMN content per capsule with zero impurities.
Acid-resistant HPMC capsules: Designed to protect NMN from gastric acid and deliver it efficiently to the small intestine.
PTP blister packaging: Maintains NMN quality at the highest level until the moment of opening.

4. Presentation at the Japanese Society of Anti-Aging Medicine and Medical Supervision

Supervised by Dr. Hibino, a leading authority in anti-aging medicine, NMN KIWAMI research findings have been presented at the Annual Meeting of the Japanese Society of Anti-Aging Medicine. This academic-level validation makes the product suitable for wellness clinics, spas, and premium fitness chains.

Support Structure for Local Distributors

Stable supply: Enhanced in-house production enables flexible response to large-volume orders

Marketing support: Provision of clinical data, high-resolution product visuals, and physician endorsement comments

Exclusive distribution considerations: Discussions regarding regional exclusivity based on performance and territory

Logistics optimization: Documentation support for international shipping, including certificates of origin

Comment from President and CEO Tomoko Iwase

“Japanese precision manufacturing can deliver new value to health-conscious consumers in the United States. NMN KIWAMI represents not just a supplement, but a science-based approach to well-aging. Collaboration with U.S. partners who share this vision will help shape the next generation of the wellness market.”

 

US FDA Certification

US FDA Certification

 

NMN KIWAMI Premium supplements package sample

NMN KIWAMI Premium supplements package sample

NMN KIWAMI by Asa Pharmaceutical

NMN KIWAMI by Asa Pharmaceutical

Media Contact

Organization: Asa Pharmaceutical Co., Ltd.

Contact Person: Tomoko Iwase

Website: https://asapharma.jp/en/

Email: Send Email

Address:1-3-9 Azabu-Juban, Minato-ku, Tokyo 106-0045

Country:Japan

Release id:42094

View source version on King Newswire:
Premium Supplement NMN KIWAMI Made in Japan with FDA Compliance Seeks Strategic U.S. Distribution Partnerships

 

file

Recent Quotes

View More
Symbol Price Change (%)
AMZN  208.73
+0.34 (0.16%)
AAPL  263.75
-0.97 (-0.37%)
AMD  190.95
-7.67 (-3.86%)
BAC  49.97
+0.16 (0.32%)
GOOG  303.56
-2.80 (-0.91%)
META  655.08
+1.52 (0.23%)
MSFT  403.93
+5.38 (1.35%)
NVDA  180.05
-2.43 (-1.33%)
ORCL  149.01
-0.24 (-0.16%)
TSLA  392.43
-10.89 (-2.70%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.